NEW YORK (GenomeWeb) – NeoGenomics and Definiens announced today that they have expanded their cancer biomarker discovery alliance to include the development and automation of assays for clinical trials and clinical testing.
NEW YORK (GenomeWeb) – NeoGenomics and Definiens announced today that they have expanded their cancer biomarker discovery alliance to include the development and automation of assays for clinical trials and clinical testing.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.